A molecular detection apparatus including an electrode, a peptide nucleic acid probe covalently bonded to the electrode and a protective layer covering portions of the electrode not having attached probes which prevents oxidation/reduction of intercalator molecules.

Patent
   5945286
Priority
Oct 23 1997
Filed
Oct 23 1997
Issued
Aug 31 1999
Expiry
Oct 23 2017
Assg.orig
Entity
Large
36
4
all paid
1. A molecular detection apparatus comprising:
an electrode;
a peptide nucleic acid probe covalently bonded to the electrode, the peptide nucleic acid probe including a chain of at least one nucleotide;
a protective layer including a thiol base molecule covering portions of the electrode not having attached probes which prevents oxidation/reduction of intercalator molecules; and
an electrical detector in electrical communication with the electrode to detect a potential/current peak occurring due to oxidation/reduction of an interaction of intercalator molecules with a hybridized target molecule and peptide nucleic acid probe, wherein the target molecule includes one of a dna molecule and an rna molecule in a complementary chain of at least one nucleotide.
5. A molecular detection apparatus comprising:
an electrode;
a peptide nucleic acid probe covalently bonded to the electrode and positioned in a solution containing target molecules and intercalator molecules, the peptide nucleic acid probe including a chain of at least one nucleotide;
a protective layer including a thiol base molecule covering portions of the electrode not having attached probes which prevents oxidation/reduction of intercalator molecules; and
an electrical detector in electrical communication with the electrode to detect a potential/current peak occurring due to oxidation/reduction of an interaction of intercalator molecules with a hybridized target molecule and peptide nucleic acid probe, wherein the target molecule includes one of a dna molecule and an rna molecule in a complementary chain of at least one nucleotide.
9. A method of identifying a target molecule comprising the steps of:
providing an electrode having a peptide nucleic acid probe, including providing a chain of at least one nucleotide attached to a peptide backbone, and a protective layer including a thiol base molecule covering portions of the electrode not having attached probes which prevents oxidation/reduction of intercalator molecules;
providing an electrical detector in electrical communication with the electrode;
supplying a solution containing a target molecule including one of a dna molecule and an rna molecule and intercalator molecules;
combining the peptide nucleic acid probe and the solution;
whereby the target molecule is free to hybridize with the peptide nucleic acid probe and the intercalator molecules are free to bond with the hybridized target molecule and peptide nucleic acid probe; and
sensing a potential/current peak resulting from the oxidation/reduction of intercalator molecules with the hybridized target molecule and peptide nucleic acid probe.
2. An apparatus as claimed in claim 1 wherein the electrical detector includes a reference electrode.
3. An apparatus as claimed in claim 1 including in addition the electrode having a plurality of identical peptide nucleic acid probes covalently bonded thereto.
4. An apparatus as claimed in claim 3 including in addition a plurality of electrodes mounted in spaced apart relation on a support, each electrode having a plurality of identical peptide nucleic acid probes covalently bonded thereto, the peptide nucleic acid probes having a different sequence in respective electrodes.
6. An apparatus as claimed in claim 5 wherein the electrical detector includes a reference electrode.
7. An apparatus as claimed in claim 5 including in addition the electrode having a plurality of identical peptide nucleic acid probes covalently bonded thereto.
8. An apparatus as claimed in claim 7 including in addition a plurality of electrodes mounted in spaced apart relation on a support, each electrode having a plurality of identical peptide nucleic acid probes covalently bonded thereto, the peptide nucleic acid probes having a different sequence in respective electrodes.
10. A method as claims in claim 9 wherein the step of sensing includes using a reference potential/current to determine the potential/current peak resulting from the oxidation/reduction of intercalator molecules with the hybridized target molecule and peptide nucleic acid probe.
11. A method as claimed in claim 9 wherein the step of providing the electrode includes providing the electrode having a plurality of identical peptide nucleic acid probes covalently bonded thereto.
12. A method as claimed in claim 11 wherein the step of providing the electrode includes providing a plurality of electrodes mounted in spaced apart relation on a support, each electrode having a plurality of identical peptide nucleic acid probes covalently bonded thereto, the peptide nucleic acid probes having a different sequence in respective electrodes.

The present invention relates to electrochemical molecular detection devices.

Recently, an increased effort has been directed toward the development of chips for molecular detection. In general, a molecular detection chip includes a substrate on which an array of binding sites is arranged. Each binding site (or hybridization site) has a respective molecular receptor (or probe) which binds or hybridizes with a molecule having a predetermined structure. A sample solution is applied to the molecular detection chip, and molecules in the sample bind or hybridize at one or more of the binding sites. The particular binding sites at which hybridization occurs are detected, and one or more molecular structures within the sample are subsequently deduced.

Of great interest are molecular detection chips for gene sequencing. These chips, often referred to as DNA chips, utilize an array of selective binding sites each having respective single-stranded DNA probes. A sample of single-stranded DNA fragments, referred to as target DNA, is applied to the DNA chip. The DNA fragments attach to one or more of the DNA probes by a hybridization process. By detecting which DNA probes have a DNA fragment hybridized thereto, a sequence of nucleotide bases within the DNA fragment can be determined.

Various approaches have been utilized to detect a hybridization event at a binding site. Many different approaches such as optical and electrical detection have been developed, but only electrical detection will be addressed herein.

The specific approach of interest is electrochemical based detection. In this approach a standard three-electrode potentiostat including an auxiliary electrode, a reference electrode and a working electrode is provided. DNA probes are covalently bonded to the surface of the working electrode by linker groups. Exposure of the single stranded DNA probes to complementary single-stranded DNA in solution will result in a hybridization reaction specifically dictated by the DNA base sequence. By applying voltemetric measurement techniques, DNA hybridization reactions are measured by observing the change in peak current caused by an oxidation/reduction reaction. This reaction is completed by introducing an intercalator that specifically binds to the minor groove of double stranded DNA through electrostatic interactions. As a result, the current peak due to oxidation/reduction of the intercalator bound to the hybridized DNA will indicate the hybridization event.

The problem with detecting a current peak associated with the oxidation/reduction reaction of the intercalator at the hybridization event is background current. The sensitivity of these types of devices is limited because intercalators may have an oxidation/reduction reaction with the working electrode surface, resulting in background current. Furthermore, while the intercalators have a tendency to bind to the minor groove of a double stranded DNA molecule through electrostatic interactions, they will also bind to a single stranded DNA, although not as readily. This further reduces sensitivity.

It would be highly advantageous, therefore, to remedy the foregoing and other deficiencies inherent in the prior art.

Accordingly, it is an object of the present invention to provide a new and improved method and apparatus for identifying molecules.

Another object of the present invention is to provide a new and improved method and apparatus for identifying molecules employing electrochemical detection.

And another object of the present invention is to provide a new and improved method and apparatus for electrochemical detection of molecules, having reduced background current.

Yet another object of the present invention is to provide a new and improved method and apparatus for electrochemical detection of molecules, having increase sensitivity.

Still another object of the present invention is to provide a new and improved method and apparatus for electrical detection of molecules, employing a probe which limits the attraction of intercalators thereto.

Briefly, to achieve the desired objects of the instant invention, in accordance with a preferred embodiment thereof, provided is a molecular detection apparatus including an electrode, a peptide nucleic acid probe covalently bonded to the electrode, and a protective layer covering portions of the electrode not having attached probes which prevents oxidation/reduction of intercalator molecules.

In a more specific aspect, an electrical detector is included which is in electrical communication with the electrode to detect a potential/current peak occurring due to oxidation/reduction of an interaction of intercalator molecules with a hybridized target molecule and peptide nucleic acid probe.

Also provided is a method of identifying a target molecule including the steps of providing an electrode having a peptide nucleic acid probe and a protective layer covering portions of the electrode not having attached probes which prevents oxidation/reduction of intercalator molecules. An electrical detector in electrical communication with the electrode is provided. A solution containing a target molecule and intercalator molecules is supplied and combined with the peptide nucleic acid probe whereby the target molecule is free to hybridize with the peptide nucleic acid probe and the intercalator molecules are free to bond with the hybridized target molecule and peptide nucleic acid probe. A potential/current peak resulting from the oxidation/reduction of intercalator molecules with the hybridized target molecule and peptide nucleic acid probe is sensed to determine the hybridization event.

The foregoing and further and more specific objects and advantages of the instant invention will become readily apparent to those skilled in the art from the following detailed description of the preferred embodiment thereof taken in conjunction with the drawings in which:

FIG. 1 is a simplified sectional side view of a molecular detection apparatus according to the present invention; and

FIG. 2 a simplified sectional side view of an array of the molecular detection apparatus of FIG. 1.

The present invention advantageously provides a molecular detection apparatus which detects the binding or hybridization of a target molecule to a molecular receptor by sensing a current peak associated with the oxidation/reduction reaction of intercalator molecules. The oxidation/reduction reaction is established when intercalators bind to the minor groove of a double stranded molecule created by the hybridization of a target molecule and a molecular receptor.

Turning now to the drawings in which like reference characters indicate like elements throughout the several views, attention is first directed to FIG. 1 which illustrates a molecular detection apparatus generally designated 10. Molecular detection apparatus 10 includes an electrode 14 on which is formed a plurality of peptide nucleic acid molecular receptors (probes) 16. In the preferred embodiment, probes 16 are covalently bonded to the surface of electrode 14 by linker groups in a known manner. Each of molecular receptors 16 carried by electrode 14 are substantially identical. It will be understood that a great many probes 16 may be carried by electrode 14 or as few as one probe.

In general, peptide nucleic acid molecular receptors 16 are selected in dependence upon a type of target molecule which is to be detected. Each probe 16 includes a synthetic molecule that has a specific affinity to the target molecule to be detected. The synthetic molecule includes a chain of at least one nucleotide which hybridizes with a complementary chain of at least one nucleotide included in the target molecule. In the present invention, probes 16 include a peptide nucleic acid (PNA) composed of nucleotide bases carried by a peptide backbone for detecting a corresponding, complementary base sequence in the target molecule.

PNA binds to single stranded DNA the same as complimentary DNA, only with more affinity and greater specificity. The use of PNA instead of DNA as probes 16 provides for greater sensitivity because PNA has no inherent charge as does DNA. This will be explained below. It is noted, however, that the scope of the invention is not limited to sensing the hybridization of a DNA molecule to PNA molecular receptors 16. For example, embodiments of the present invention can also be utilized to detect RNA hybridization.

Molecular detection apparatus 10 further includes an electrical detector 18, in electrical communication with electrode 14 to detect a potential/current peak occurring due to oxidation/reduction of an interaction of intercalator molecules with a hybridized target molecule and peptide nucleic acid probe 16. Electrical detector 18 is not described in detail, as any conventional electrical detection device typically used in voltammetric measurement techniques can be employed. As a specific example, electrical detector 18 can be a standard three-electrode potentiostat having an auxiliary electrode, a reference electrode and a working electrode (electrode 14).

A protective layer 20 covers portions of electrode 14 not having attached probes 16. This prevents oxidation/reduction of intercalator molecules to the surface of electrode 14. In the preferred embodiment, protective layer 20 is a monolayer of a thiol base molecule which is inert and can be self-assembled on the surface of electrode 14.

Turning now to FIG. 2, a side view of a molecular detection apparatus 30 including an array of electrodes 14 carried by a substrate 12 is illustrated. Peptide nucleic acid probes 16 on respective electrodes 14 differ in base sequence for simultaneous detection of a plurality of different target molecules within a single array.

To identify a molecule, a solution 32 containing target molecules 33 and intercalator molecules 34 is brought into contact with probes 16. Target molecules 33 are free to hybridize with peptide nucleic acid probes 16. It will be understood that substantially any number of target molecules 33 may be present in the solution. Intercalator molecules 34 are free to bond with the double stranded molecule created by the hybridization of target molecules 33 and peptide nucleic acid probes 16.

Hybridization reactions are measured by observing the change in peak current caused by an oxidation/reduction reaction. This reaction is completed by introducing intercalator molecules 34 which specifically bind to the minor groove of a double stranded molecule through electrostatic interactions. As a result, the current peak due to oxidation/reduction of the intercalator bound to the hybridized molecule will indicate the hybridization event.

A potential/current peak resulting from the oxidation/reduction of intercalator molecules with the hybridized target molecule and peptide nucleic acid probe is sensed. Determining a current peak is accomplished by using a reference potential/current to determine the potential/current peak resulting from the oxidation/reduction of intercalator molecules with the hybridized target molecule and peptide nucleic acid probe. Sensitivity is increased by widening the difference between the reference potential/current and the potential/current peak.

In conventional devices, the background current caused by intercalators having an oxidation/reduction reaction with the working electrode surface and binding to single stranded DNA probes having an inherent charge which can attract intercalator molecules, narrows the difference, reducing sensitivity and requiring a relatively large potential/current peak to be noticeable over the background. By forming protective layer 20 on electrodes 14 and by using probes 16 formed of single stranded peptide nucleic acid molecules, background current is substantially reduced, increasing sensitivity. The reduction in background current occurs because protective layer 20 and probes 16 do not have any inherent charge which can attract intercalator molecules 34. Since intercalator molecules 34 are not attracted they will not contribute to an oxidation/reduction reaction to produce a current.

Thus provides is a new and improved method and apparatus for identifying molecules employing electrochemical detection having sensitivity by employing molecular receptors having no inherent charge.

Various modifications and changes to the embodiments herein chosen for purposes of illustration will readily occur to those skilled in the art. Other modifications and variations may be made by those skilled in the art without departing from the scope of the invention as defined by the following claims.

Shieh, Chan-Long, Krihak, Michael

Patent Priority Assignee Title
11168365, May 26 2017 VIBRANT HOLDINGS, LLC Photoactive compounds and methods for biomolecule detection and sequencing
11565231, Feb 07 2012 VIBRANT HOLDINGS, LLC Substrates, peptide arrays, and methods
11674956, Sep 28 2012 VIBRANT HOLDINGS, LLC Methods, systems, and arrays for biomolecular analysis
11740202, Sep 01 2017 ADVANCED TEAR DIAGNOSTICS, LLC Point-of-care apparatus and methods for detecting cancer using electrochemical impedance or capacitance spectroscopy
11815512, Sep 28 2012 VIBRANT HOLDINGS, LLC Methods, systems, and arrays for biomolecular analysis
6235484, May 03 1999 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Polynucleotide probes for detection and quantitation of actinomycetes
6264825, Jun 23 1998 CLINICAL MICRO SENSORS, INC , DBA OSMETECH TECHNOLOGY INC Binding acceleration techniques for the detection of analytes
6290839, Jun 23 1998 OSMETECH TECHNOLOGY INC Systems for electrophoretic transport and detection of analytes
6326486, May 03 1999 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Polynucleotide probes for detection and quantitation of bacteria in the family enterobacteriaceae
6376186, May 03 1999 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Polynucleotide probes for detection and quantitation of staphylococcus
6413792, Apr 24 2000 Life Technologies Corporation Ultra-fast nucleic acid sequencing device and a method for making and using the same
6756223, Dec 18 2001 Motorola, Inc. Electro-chemical analysis device with integrated thermal sensor and method for monitoring a sample using the device
6761816, Jun 23 1998 CLINICAL MICRO SENSORS, INC , DBA OSMETECH TECHNOLOGY INC Printed circuit boards with monolayers and capture ligands
6818109, Sep 29 2000 Kabushiki Kaisha Toshiba Nucleic acid detections sensor
6821770, May 03 1999 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
7001792, Apr 24 2000 Life Technologies Corporation Ultra-fast nucleic acid sequencing device and a method for making and using the same
7087148, Jun 23 1998 OSMETECH TECHNOLOGY INC Binding acceleration techniques for the detection of analytes
7172897, Jan 11 2000 Roche Molecular Systems, Inc Devices and methods for biochip multiplexing
7312087, Jan 11 2001 Roche Molecular Systems, Inc Devices and methods for biochip multiplexing
7449328, May 03 1999 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Probe matrix-based device for identifying microorganisms
7491311, Sep 29 2000 Kabushiki Kaisha Toshiba Nucleic acid detection sensor
7510636, Sep 29 2000 Kabushiki Kaisha Toshiba Nucleic acid detection sensor
7655129, Jun 23 1998 CLINICAL MICRO SENSORS, INC , DBA OSMETECH TECHNOLOGY INC Binding acceleration techniques for the detection of analytes
7687258, May 20 2002 Direct electric biological agent detector
7718048, Aug 23 2002 Toshiba Medical Systems Corporation Base sequence detecting electrode, base sequence detecting device and base sequence detecting method
7935481, Jul 26 1999 Roche Molecular Systems, Inc Sequence determination of nucleic acids using electronic detection
8017340, Dec 23 2004 Abbott Point of Care Inc. Nucleic acid separation and amplification
8048633, Dec 23 2004 Abbott Point of Care Inc. Methods of performing nucleic acid amplification assays using modified primers
8232582, Apr 24 2000 Life Technologies Corporation Ultra-fast nucleic acid sequencing device and a method for making and using the same
8703445, Dec 29 2005 Abbott Point of Care Inc. Molecular diagnostics amplification system and methods
8883487, Dec 23 2004 ABBOTT POINT OF CARE INC Molecular diagnostics system and methods
9063081, Apr 24 2000 Life Technologies Corporation Ultra-fast nucleic acid sequencing device and a method for making and using the same
9228976, Apr 24 2000 Life Technologies Corporation Method and apparatus for detecting nucleotides
9410923, Apr 24 2000 Life Technologies Corporation Ultra-fast nucleic acid sequencing device and a method for making and using the same
9752182, Dec 23 2004 Abbott Point of Care Inc. Molecular diagnostics system and methods
9758824, Apr 24 2000 Life Technologies Corporation Ultra-fast nucleic acid sequencing device and a method for making and using the same
Patent Priority Assignee Title
5599695, Feb 27 1995 AFFYMETRIX INC , A CORP OF DE Printing molecular library arrays using deprotection agents solely in the vapor phase
5632957, Jul 07 1994 GAMIDA FOR LIFE, B V Molecular biological diagnostic systems including electrodes
5653939, Apr 23 1992 Massachusetts Institute of Technology; Houston Advanced Research Center; Baylor College of Medicine Optical and electrical methods and apparatus for molecule detection
5700922, Dec 24 1991 ISIS PHARMACEUTICALS INC PNA-DNA-PNA chimeric macromolecules
//////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 21 1997KRIHAK, MICHAELMotorola, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0087940257 pdf
Oct 21 1997SHIEH, CHAN-LONGMotorola, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0087940257 pdf
Oct 23 1997Motorola, Inc.(assignment on the face of the patent)
Jul 31 2010Motorola, IncMotorola Mobility, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0256730558 pdf
Jun 22 2012Motorola Mobility, IncMotorola Mobility LLCCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0292160282 pdf
Oct 28 2014Motorola Mobility LLCGoogle Technology Holdings LLCASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0344300001 pdf
Date Maintenance Fee Events
Dec 30 2002M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Jan 19 2007M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Jan 03 2011M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Aug 31 20024 years fee payment window open
Mar 03 20036 months grace period start (w surcharge)
Aug 31 2003patent expiry (for year 4)
Aug 31 20052 years to revive unintentionally abandoned end. (for year 4)
Aug 31 20068 years fee payment window open
Mar 03 20076 months grace period start (w surcharge)
Aug 31 2007patent expiry (for year 8)
Aug 31 20092 years to revive unintentionally abandoned end. (for year 8)
Aug 31 201012 years fee payment window open
Mar 03 20116 months grace period start (w surcharge)
Aug 31 2011patent expiry (for year 12)
Aug 31 20132 years to revive unintentionally abandoned end. (for year 12)